Lung targeted liposomes for treating ARDS
ARDS 치료를 위한 폐 표적 리포솜
Article
[키워드] accumulate
accumulation
acute respiratory distress
acute respiratory distress syndrome
Administered
administration
alveolar
approach
ARDS
BAL
Bronchoalveolar lavage
C57BL/6
characterized
combined treatment
COPD
COVID-19
COVID-19 infections
cysteine
cytokine secretion
distal
DPPC
drug
Efficiency
encapsulation
endotracheal
exhibited
Gas exchange
Hypoxemia
IL-1β
IL-6
impair
infections
Inflammation
Inflammatory marker
inflammatory markers
intravenous
intravenously
lipid composition
Lipid nanoparticles
lipopolysaccharide
Liposome
lung
lung damage
Lung diseases
lung disorders
lung endothelial
lung epithelial
Lung inflammation
Lungs
Macrophage
macrophages
marker
medication
Methylprednisolone
mice
mortality rate
mortality rates
MPS
mucolytic agent
Mucus
N-acetyl cysteine
NAC
nanoparticle
Nanotechnology
nitric oxide
outcome
Patient
penetration
provided
pulmonary
reached
reduce
reducing
Region
respiratory
respiratory distress
Respiratory distress syndrome
secretion
steroid
syndrome
therapeutic
therapeutic effect
therapeutic efficacy
TNFα
Treatment
Treatment outcome
were assessed
[DOI] 10.1016/j.jconrel.2022.03.028 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jconrel.2022.03.028 PMC 바로가기 [Article Type] Article